Literature DB >> 28860340

Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival.

Inge G P Geelen1, Noortje Thielen2,3, Jeroen J W M Janssen2, Mels Hoogendoorn4, Tanja J A Roosma2, Sten P Willemsen5,6, Peter J M Valk7, Otto Visser8, Jan J Cornelissen7, Peter E Westerweel9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28860340      PMCID: PMC5709118          DOI: 10.3324/haematol.2017.175265

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.

Authors:  Susan O'Brien; Ellin Berman; Hossein Borghaei; Daniel J Deangelo; Marcel P Devetten; Steven Devine; Harry P Erba; Jason Gotlib; Madan Jagasia; Joseph O Moore; Tariq Mughal; Javier Pinilla-Ibarz; Jerald P Radich; Neil P Shah Md; Paul J Shami; B Douglas Smith; David S Snyder; Martin S Tallman; Moshe Talpaz; Meir Wetzler
Journal:  J Natl Compr Canc Netw       Date:  2009-10       Impact factor: 11.908

2.  Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Authors:  Hannah Bower; Magnus Björkholm; Paul W Dickman; Martin Höglund; Paul C Lambert; Therese M-L Andersson
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

Review 3.  Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Michele Baccarani; Giuseppe Saglio; John Goldman; Andreas Hochhaus; Bengt Simonsson; Frederick Appelbaum; Jane Apperley; Francisco Cervantes; Jorge Cortes; Michael Deininger; Alois Gratwohl; François Guilhot; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Dietger Niederwieser; Richard Silver; Rudiger Hehlmann
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

4.  Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib.

Authors:  Stuart L Goldberg; Lei Chen; Annie Guerin; Alexander R Macalalad; Nathan Liu; Michael Kaminsky; Solveig G Ericson; Eric Q Wu
Journal:  Curr Med Res Opin       Date:  2013-06-21       Impact factor: 2.580

5.  The impact of health care settings on survival time of patients with chronic myeloid leukemia.

Authors:  Michael Lauseker; Joerg Hasford; Markus Pfirrmann; Rüdiger Hehlmann
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113

6.  Chronic Myelogenous Leukemia, Version 1.2014.

Authors:  Susan O'Brien; Jerald P Radich; Camille N Abboud; Mojtaba Akhtari; Jessica K Altman; Ellin Berman; Daniel J DeAngelo; Michael Deininger; Steven Devine; Amir T Fathi; Jason Gotlib; Madan Jagasia; Patricia Kropf; Joseph O Moore; Arnel Pallera; Javier Pinilla-Ibarz; Vishnu Vb Reddy; Neil P Shah; B Douglas Smith; David S Snyder; Meir Wetzler; Kristina Gregory; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2013-11       Impact factor: 11.908

7.  Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia.

Authors:  Annie Guérin; Lei Chen; Katherine Dea; Eric Q Wu; Stuart L Goldberg
Journal:  J Med Econ       Date:  2013-11-26       Impact factor: 2.448

8.  Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase.

Authors:  Annie Guérin; Lei Chen; Katherine Dea; Eric Q Wu; Stuart L Goldberg
Journal:  Curr Med Res Opin       Date:  2014-03-21       Impact factor: 2.580

Review 9.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors:  Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 10.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113

View more
  1 in total

1.  A comprehensive eHealth implementation guide constructed on a qualitative case study on barriers and facilitators of the digital care platform CMyLife.

Authors:  Nicole Ma Blijlevens; Rosella Pmg Hermens; Lynn Verweij; Yolba Smit
Journal:  BMC Health Serv Res       Date:  2022-06-06       Impact factor: 2.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.